UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Anti-DNA antibodies--overview of assays and clinical correlations
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Article
  • Authors:
    Rahman A, Hiepe F
  • Publication date:
    2002
  • Pagination:
    770, 773
  • Journal:
    Lupus
  • Volume:
    11
  • Issue:
    12
  • Print ISSN:
    0961-2033
  • Keywords:
    ACCOUNT, activity, anti-DNA, antibodies, Antibody, APOPTOTIC CELLS, ASSAY, assessment, Autoantibodies, British, cell, CELLS, CLEARANCE, clinical, Condition, control, Correlation, disease, DNA, formation, HEALTHY, IM, INDEX, Indices, INDUCE, interpretation, LA, LEVEL, link, Lupus, May, NUMBER, Patient, patients, RANGE, REACTIVITY, renal, SERA, serum, SLE
  • Notes:
    UI - 22416377 LA - eng PT - Journal Article DA - 20030116 IS - 0961-2033 SB - IM CY - England
Abstract
Many authors have studied the links between levels of anti-dsDNA antibodies and disease activity in patients with SLE. Interpretation of these studies must take into account the facts that there are a range of possible assays for anti-dsDNA and a number of indices available for assessing disease activity. A recent study compared levels of various autoantibodies with organ specific disease activity assessed during the British Isles Lupus Assessment Group (BILAG) index. Anti-dsDNA and anti- heparan sulphate levels were more likely to be raised in patients with renal than non-renal disease. Some anti-DNA antibodies are actually anti-nucleosome antibodies, which lose DNA reactivity when purified under dissociating conditions. Patients with SLE have significantly increased levels of nucleosomes in their sera compared with healthy controls. In patients with SLE, reduced clearance of nucleosomes released from apoptotic cells may induce the formation of anti- nucleosome antibodies
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by